Data

Participation in exercise and sport for individuals with minimal disability from multiple sclerosis: Quantitative feasibility data

James Cook University
Smith, Moira ; Barker, Ruth ; Williams, Gavin
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.25903/rsaw-pk29&rft.title=Participation in exercise and sport for individuals with minimal disability from multiple sclerosis: Quantitative feasibility data&rft.identifier=10.25903/rsaw-pk29&rft.publisher=James Cook University&rft.description=The flexible exercise participation program (FEPP) is a novel intervention developed to enable individuals with multiple sclerosis (MS) participate and progress in an exercise or sport of their choice. The FEPP is underpinned by guidelines on aerobic exercise for individuals with MS and is supported by a physiotherapist using behaviour change techniques. As part of a FEPP feasibility trial, the aims of this study were to: 1) assess the feasibility of the FEPP for individuals with minimal disability from MS. 2) assess the feasibility of a larger clinical trial to evaluate the impact of the FEPP. FEPP feasibility was assessed with the Goal Attainment Scale (GAS) T-score as the primary outcome. Secondary outcomes included exercise participation, high-level mobility (HiMAT), vitality (Subjective Vitality Scale), biomarkers for inflammation (cytokines levels [IL2, IL4, IL6, IL10, TNF and IFNγ], and acceptability (participant survey). Trial feasibility was assessed via process, resource, management and scientific outcomes. This data set includes the study protocol, recording documents, feasibility outcomes, raw clinical outcome data and statistical analysis. Software/equipment used to create/collect the data: Qualtrics Excel NVivo software version 12 BD Cytometric bead array (CBA) Hu Th1/Th2 Cytokine kit II: BD Biosciences Software/equipment used to manipulate/analyse the data: SPSS version 27 GraphPad version 9.1.2&rft.creator=Smith, Moira &rft.creator=Barker, Ruth &rft.creator=Williams, Gavin &rft.date=2021&rft.coverage=138.171053,-22.755921 151.181401,-22.634293 142.522487,-10.401378 138.127099,-16.636192 138.19878,-22.796439&rft.coverage=Queensland, Australia&rft_rights=Once access to the data has been obtained via negotiation with the Data Manager, use of the dataset is governed by the CC-BY NC 4.0 licence.&rft_rights=CC BY-NC 4.0: Attribution-Noncommercial 4.0 International http://creativecommons.org/licenses/by-nc/4.0&rft_subject=multiple sclerosis&rft_subject=exercise&rft_subject=participation&rft_subject=biomarkers&rft_subject=cytokines&rft.type=dataset&rft.language=English Access the data

Licence & Rights:

Non-Commercial Licence view details
CC-BY-NC

CC BY-NC 4.0: Attribution-Noncommercial 4.0 International
http://creativecommons.org/licenses/by-nc/4.0

Once access to the data has been obtained via negotiation with the Data Manager, use of the dataset is governed by the CC-BY NC 4.0 licence.

Access:

Conditions apply view details

Conditional: Contact [email protected] to request access to this data.

Full description

The flexible exercise participation program (FEPP) is a novel intervention developed to enable individuals with multiple sclerosis (MS) participate and progress in an exercise or sport of their choice. The FEPP is underpinned by guidelines on aerobic exercise for individuals with MS and is supported by a physiotherapist using behaviour change techniques. As part of a FEPP feasibility trial, the aims of this study were to:

1) assess the feasibility of the FEPP for individuals with minimal disability from MS.

2) assess the feasibility of a larger clinical trial to evaluate the impact of the FEPP.

FEPP feasibility was assessed with the Goal Attainment Scale (GAS) T-score as the primary outcome. Secondary outcomes included exercise participation, high-level mobility (HiMAT), vitality (Subjective Vitality Scale), biomarkers for inflammation (cytokines levels [IL2, IL4, IL6, IL10, TNF and IFNγ], and acceptability (participant survey). Trial feasibility was assessed via process, resource, management and scientific outcomes.

This data set includes the study protocol, recording documents, feasibility outcomes, raw clinical outcome data and statistical analysis.

Software/equipment used to create/collect the data: Qualtrics Excel NVivo software version 12 BD Cytometric bead array (CBA) Hu Th1/Th2 Cytokine kit II: BD Biosciences

Software/equipment used to manipulate/analyse the data: SPSS version 27 GraphPad version 9.1.2

Created: 2021-12-07

Data time period: 06 12 2019 to 30 12 2020

This dataset is part of a larger collection

Click to explore relationships graph

138.171053,-22.755921 151.181401,-22.634293 142.522487,-10.401378 138.127099,-16.636192 138.19878,-22.796439

144.65425,-16.5989085

text: Queensland, Australia

Subjects

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers
  • DOI : 10.25903/RSAW-PK29
  • Local : researchdata.jcu.edu.au//published/8caa14b040f311ec8178bfe67171bb3e
ACN 633 798 857